OR WAIT null SECS
Research report: 41% of US cannabis consumers self-identify as medical consumers
New Frontier Data, a data, analytics and business intelligence company that focuses on the cannabis industry, released its latest industry report, Medical Cannabis & Pharmaceuticals: Growth & Disruption in US Healthcare, highlighting medical cannabis patients as a consumer group with reasons for consumption that are differerent from those of recreational users. The rise of cannabis in the wellness space, the legal market expansion and consumer sentiment shifting toward medical cannabis as a possible alternative to prescription medications are contributing to the possible disruption of the pharmaceutical market.
Incorporating New Frontier Data’s analysis on the cannabis consumer, the report delves into medical cannabis preferences and behaviors, consumer purchasing and consumption habits, and the potential impact on the pharma industry.